Ryan D. Maynard - 12 Sep 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (TVRD)

Role
Chief Financial Officer
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Issuer symbol
TVRD
Transactions as of
12 Sep 2022
Net transactions value
$0
Form type
4
Filing time
14 Sep 2022, 16:42:23 UTC
Previous filing
14 Jun 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARA Stock Option (Right to Buy) Award $0 +225,000 $0.000000 225,000 12 Sep 2022 Common Stock 225,000 $10.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares will vest and become exercisable on September 12, 2023 and the remainder will vest over the following 36 equal monthly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date.